Description
Glycopyrrolate 25 mcg + Formoterol Fumarate 6 mcg
GLUREST–F Capsules are a dual bronchodilator formulation combining Glycopyrrolate, a long-acting muscarinic antagonist (LAMA), and Formoterol Fumarate, a long-acting β₂-adrenergic agonist (LABA). This combination is specifically designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
-
Glycopyrrolate (LAMA) – Blocks muscarinic receptors in the airway smooth muscles, preventing bronchoconstriction and promoting sustained bronchodilation.
-
Formoterol Fumarate (LABA) – Provides rapid and long-lasting relaxation of bronchial smooth muscles by stimulating β₂-adrenergic receptors.
Together, they deliver complementary bronchodilation, improving airflow and reducing COPD symptoms.
Benefits
-
Dual bronchodilator therapy (LAMA + LABA) for superior symptom control
-
Rapid onset with long-lasting effect (up to 12 hours)
-
Reduces frequency of COPD exacerbations
-
Enhances lung function, reduces breathlessness, and improves quality of life
